2,3-DIHYDROXYBUTYL 2-ETHOXY-1-((2'-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)-(1,1'-BIPHENYL)-4-YL)METHYL)-1H-BENZO(D)IMIDAZOLE-7-CARBOXYLATE
UNII PR86492YPW
Substance Identification & Data
This profile provides standardized clinical and technical data for 2,3-dihydroxybutyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-(1,1'-biphenyl)-4-yl)methyl)-1h-benzo(d)imidazole-7-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PR86492YPW.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H28N4O7 IJKPDJTZUXSXTM-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2,3-dihydroxybutyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-(1,1'-biphenyl)-4-yl)methyl)-1h-benzo(d)imidazole-7-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.